Docosahexaenoic acid (DHA) supplementation attenuates changes in the concentration, phenotype, and response of immune peripheral blood cells in breast cancer patients undergoing neoadjuvant therapy. Secondary findings from the DHA-WIN trial

Abstract Background Breast cancer neoadjuvant therapy may negatively impact the immune system. As a secondary outcome of the docosahexaenoic acid (DHA) for women with breast cancer in the neoadjuvant setting (DHA-WIN trial), we sought to assess the effects of an intervention with DHA on parameters o...

詳細記述

書誌詳細

主要な著者:	Jaqueline Munhoz, Marnie Newell, Susan Goruk, Sunita Ghosh, Dhruvesh Patel, Anil Abraham Joy, Gilbert Bigras, Vera Mazurak, Kerry S. Courneya, Denise G. Hemmings, Catherine J. Field
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2025-05-01
シリーズ:	Breast Cancer Research
主題:	Immune response Pathological complete response Long-chain polyunsaturated fatty acid Cytokines Immune phenotype
オンライン･アクセス:	https://doi.org/10.1186/s13058-025-02048-z
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!